

HY-171035 · 5 mg
MedChemExpress · Cat: HY-171035
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/prl-295.htmlDescription
PRL-295 is an orally active inhibitor targeting Keap1-Nrf2 interaction. PRL-295 increases the thermal stability of Keap1 and disrupts its interaction with Nrf2, thereby activating the Nrf2-dependent transcriptional target NAD P H:quinone oxidoreductase 1 NQO1 . PRL-295 protects against Acetaminophen HY-66005 -induced liver injury in mice.